Levina et al. provided compelling evidence for CCL11’s pivotal role in ovarian carcinoma progression, demonstrating its significant contribution to tumor cell proliferation and invasion through the CCR2-, CCR3-, and CCR5-mediated signaling pathways. The gene discussed is CCL11; the disease is ovarian carcinoma.